Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation and High Intensity Focused Ultrasound), Mode of Treatment (Surgical Ablation, Lararscopic Ablation and Percutaneous Ablation), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, Breast Cancer and Prostate Cancer), End users (Hospitals and Clinics) - Analysis & Forecast 2019-2030.
Report ID : 99 | Published Date : May 2019 | Pages : 150 | Region : Global | Report Code : MD-51
Tumor Ablation Market Overviews and Introduction
The Tumor Ablation Market is estimated to be over US$ 370 Million in 2018. It is anticipated to grow in double digit during the forecast period, 2019 to 2030.
Tumor ablation is a minimally invasive technique commonly used in the treatment of tumors of the liver, kidney, lung and bones. The treatment procedure involves use of probes to burn or freeze cancer cells at the site of tumor. It is used as an option by the people for whom chemotherapy fails or who cannot undergo surgery. It is also used as a first line treatment in patients who have smaller tumors such as small hepatocellular carcinomas or benign tumor in liver.
This market is driven by increase in number of cancer cases and also by technological advancements in the ablation devices. In addition, increasing healthcare awareness, growing support from the government and the surging awareness regarding side effects of drugs are expected to drive the growth of tumor ablation market. However, strict regulatory requirements and the long approval time for the product launches are some of the factors, restraining the growth of this market to a certain extent.
Tumor Ablation Market by Technology
On the basis of the technology, this market is segmented into radiofrequency ablation, microwave ablation, cryoablation and high intensity focused ultrasound (HIFU). Radiofrequency ablation is estimated to account for the largest share of this market.
Tumor Ablation Market by Mode of Treatment
On the basis of mode of treatment, the market can be segmented into surgical ablation, laparoscopic ablation and percutaneous ablation. Surgical ablation accounted for largest share of the market owing to, rising prevalence of breast and liver cancer patients, which require open surgical procedures.
Tumor Ablation Market by Application
On the basis of application, the market can be segmented by lung cancer, liver cancer, kidney cancer, bone metastasis, breast cancer, prostate cancer and other cancers. Liver cancer segment is expected to account for the largest share of this market. Lung cancer market is expected to register highest CAGR during the forecast period owing to, growing number of lung cancer cases.
Tumor Ablation Market by End User
On the basis of end user, the market can be segmented into hospitals and cancer specialty clinics. Cancer specialty clinics are expected to account for largest share of the tumor ablation market owing to preference for cancer specialty clinics.
Tumor Ablation Market by Region
On the basis of geographical distribution, the tumor ablation market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America is leading this market, owing to increasing demand for minimal invasive surgeries and increase in prevalence of cancer specially breast cancer. Asia-Pacific is likely to register fastest growth in CAGR during the forecast period, owing to presence of higher number of patients, increasing prevalence of cancer and government support in the region.
Tumor Ablation Market Prominent Players
The prominent players in the tumor ablation market are. AngioDynamics, Medtronic, Boston Scientific Corporation, NeuWave Medical, Inc., HealthTronics, Inc., Galil Medical Inc., Misonix, Sonacare Medical, MERMAID MEDICAL A/S and Integra LifeSciences Corporation among others.